Eli Lilly and Boehringer Ingelheim's insulin glargine receives tentative approval from the FDA Aug. 19, 2014
Novel small-molecule GK-GKRP inhibitors with the ability to lower blood glucose levels in vivo Aug. 14, 2014
Pfizer presents DGAT2 inhibitors with activity in preclinical models of metabolic disease Aug. 14, 2014
RSS